Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleNEUROPHARMACOLOGY

Appetite-Boosting Property of Pro-Melanin-Concentrating Hormone131–165 (Neuropeptide-Glutamic Acid-Isoleucine) Is Associated with Proteolytic Resistance

Laurence Maulon-Feraille, Odile Della Zuana, Thomas Suply, Carole Rovere-Jovene, Valérie Audinot, Nigel Levens, Jean A. Boutin, Jacques Duhault and Jean-Louis Nahon
Journal of Pharmacology and Experimental Therapeutics August 2002, 302 (2) 766-773; DOI: https://doi.org/10.1124/jpet.302.2.766
Laurence Maulon-Feraille
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Odile Della Zuana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Suply
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carole Rovere-Jovene
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valérie Audinot
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nigel Levens
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean A. Boutin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacques Duhault
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Louis Nahon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Melanin-concentrating hormone (MCH) is a cyclic neuropeptide, with a major role in stimulation of feeding behavior in mammals. MCH signals in the brain occur via two seven-transmembrane G protein-coupled receptors, namely MCH1 (SLC-1, MCH1, MCH-R1, or MCH-1R) and MCH2 (SLT, MCH2, MCH-R2, or MCH-2R). In this study, we demonstrate that the pro-MCH131–165 peptide neuropeptide-glutamic acid-isoleucine (NEI)-MCH is more potent than MCH in stimulating feeding in the rat. Using rat MCH1-expressed human embryonic kidney 293 cells, we show that NEI-MCH exhibits 5-fold less affinity in a binding assay and 2-fold less potency in a cAMP assay than MCH. A similar 7- to 8-fold shift in potency was observed in a Ca2+i assay using rat MCH1 or human MCH2-transfected Chinese hamster ovary cell models. This demonstrates that NEI-MCH is not a better agonist than MCH at either of the MCH receptors. Then, we compared the proteolysis resistance of MCH and NEI-MCH to rat brain membrane homogenates and purified proteases. Kinetics of peptide degradation using brain extracts indicated at1/2 of 34.8 min for MCH and 78.5 min for NEI-MCH with a specific pattern of cleavage of MCH but not NEI-MCH by exo- and endo-proteases. Furthermore, MCH was found highly susceptible to degradation by aminopeptidase M and endopeptidase 24.11, whereas NEI-MCH was fully resistant to proteolysis by these enzymes. Therefore, our results strongly suggest that reduced susceptibility to proteases of NEI-MCH compared with MCH account for its enhanced activity in feeding behavior. NEI-MCH represents therefore the first MCH natural functional “superagonist” so far described.

Footnotes

  • This work was supported in part by grants from the Institut de Recherche Servier, the Institut Danone, and the Centre National de la Recherche Scientifique to L.M.-F., T.S., C.R.-J., and J.L.N. L.M-F. and T.S. were recipients of “Nestle” and “Conventions Industrielles de Formation par la Recherche” (Association Nationale de la Recherche Technique, Institut de Recherche Servier, Centre National de la Recherche Scientifique) fellowships, respectively.

  • Abbreviations:
    MCH
    melanin-concentrating hormone
    NEI
    neuropeptide-glutamic acid-isoleucine
    IR
    immunoreactive
    CSF
    cerebrospinal fluid
    BSA
    bovine serum albumin
    RP
    reverse phase
    HPLC
    high-performance liquid chromatography
    CHO
    Chinese hamster ovary
    PMSF
    phenylmethylsulfonyl fluoride
    MALDI-TOF
    matrix-assisted laser desorption ionization/time of flight
    MS
    mass spectroscopy
    Rt
    retention time
    [125I]S36057
    (S-S cyclic)(3-iodo)Tyr-8-amino-3,6-dioxyoctanoyl-Arg-Cys-Met-Leu-Gly-Arg-Val-Phe-Arg-Pro-Cys-Trp
    • Received October 29, 2001.
    • Accepted April 22, 2002.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 302 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 302, Issue 2
1 Aug 2002
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Appetite-Boosting Property of Pro-Melanin-Concentrating Hormone131–165 (Neuropeptide-Glutamic Acid-Isoleucine) Is Associated with Proteolytic Resistance
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleNEUROPHARMACOLOGY

Appetite-Boosting Property of Pro-Melanin-Concentrating Hormone131–165 (Neuropeptide-Glutamic Acid-Isoleucine) Is Associated with Proteolytic Resistance

Laurence Maulon-Feraille, Odile Della Zuana, Thomas Suply, Carole Rovere-Jovene, Valérie Audinot, Nigel Levens, Jean A. Boutin, Jacques Duhault and Jean-Louis Nahon
Journal of Pharmacology and Experimental Therapeutics August 1, 2002, 302 (2) 766-773; DOI: https://doi.org/10.1124/jpet.302.2.766

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleNEUROPHARMACOLOGY

Appetite-Boosting Property of Pro-Melanin-Concentrating Hormone131–165 (Neuropeptide-Glutamic Acid-Isoleucine) Is Associated with Proteolytic Resistance

Laurence Maulon-Feraille, Odile Della Zuana, Thomas Suply, Carole Rovere-Jovene, Valérie Audinot, Nigel Levens, Jean A. Boutin, Jacques Duhault and Jean-Louis Nahon
Journal of Pharmacology and Experimental Therapeutics August 1, 2002, 302 (2) 766-773; DOI: https://doi.org/10.1124/jpet.302.2.766
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CVN424, a novel GPR6 inverse agonist for Parkinson's disease
  • Methylone Brain Concentrations and Pharmacodynamic Effects
  • Oxysterols and Ethanol
Show more Neuropharmacology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics